Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 2/2016

Open Access 01-02-2016 | Original Article

Simplified risk stratification criteria for identification of patients with MRSA bacteremia at low risk of infective endocarditis: implications for avoiding routine transesophageal echocardiography in MRSA bacteremia

Authors: P. Buitron de la Vega, P. Tandon, W. Qureshi, Y. Nasr, R. Jayaprakash, S. Arshad, D. Moreno, G. Jacobsen, K. Ananthasubramaniam, M. Ramesh, M. Zervos

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 2/2016

Login to get access

Abstract

The aim of this study was to identify patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia with low risk of infective endocarditis (IE) who might not require routine trans-esophageal echocardiography (TEE). We retrospectively evaluated 398 patients presenting with MRSA bacteremia for the presence of the following clinical criteria: intravenous drug abuse (IVDA), long-term catheter, prolonged bacteremia, intra-cardiac device, prosthetic valve, hemodialysis dependency, vertebral/nonvertebral osteomyelitis, cardio-structural abnormality. IE was diagnosed using the modified Duke criteria. Of 398 patients with MRSA bacteremia, 26.4 % of cases were community-acquired, 56.3 % were health-care-associated, and 17.3 % were hospital-acquired. Of the group, 44 patients had definite IE, 119 had possible IE, and 235 had a rejected diagnosis. Out of 398 patients, 231 were evaluated with transthoracic echocardiography (TTE) or TEE. All 44 patients with definite IE fulfilled at least one criterion (sensitivity 100 %). Finally, a receiver operator characteristic (ROC) curve was obtained to evaluate the total risk score of our proposed criteria as a predictor of the presence of IE, and this was compared to the ROC curve of a previously proposed criteria. The area under the ROC curve for our criteria was 0.710, while the area under the ROC curve for the criteria previously proposed was 0.537 (p < 0.001). The p-value for comparing those 2 areas was less than 0.001, indicating statistical significance. Patients with MRSA bacteremia without any of our proposed clinical criteria have very low risk of developing IE and may not require routine TEE.
Literature
1.
go back to reference Kaasch AJ, Fowler VG Jr, Rieg S et al (2011) Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia. Clin Infect Dis 53:1–9PubMedCentralCrossRefPubMed Kaasch AJ, Fowler VG Jr, Rieg S et al (2011) Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia. Clin Infect Dis 53:1–9PubMedCentralCrossRefPubMed
2.
go back to reference Bassetti M, Trecarichi EM, Mesini A et al (2011) Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia. Clin Microbiol Infect 18:862–869CrossRefPubMed Bassetti M, Trecarichi EM, Mesini A et al (2011) Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia. Clin Microbiol Infect 18:862–869CrossRefPubMed
3.
go back to reference Benfield T, Espersen F, Frimodt-Moller N et al (2007) Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect 13:257–263CrossRefPubMed Benfield T, Espersen F, Frimodt-Moller N et al (2007) Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect 13:257–263CrossRefPubMed
4.
go back to reference El-Ahdab F, Benjamin DK Jr, Wang A et al (2005) Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia. Am J Med 118:225–229CrossRefPubMed El-Ahdab F, Benjamin DK Jr, Wang A et al (2005) Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia. Am J Med 118:225–229CrossRefPubMed
5.
go back to reference Rieg S, Peyerl-Hoffmann G, de With K, Theilacker C et al (2009) Mortality of S. aureus bacteremia and infectious diseases specialist consultation—a study of 521 patients in Germany. J Infect 59:232–239CrossRefPubMed Rieg S, Peyerl-Hoffmann G, de With K, Theilacker C et al (2009) Mortality of S. aureus bacteremia and infectious diseases specialist consultation—a study of 521 patients in Germany. J Infect 59:232–239CrossRefPubMed
6.
go back to reference Hoen B, Alla F, Selton-Suty C et al (2002) Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 288:75–81CrossRefPubMed Hoen B, Alla F, Selton-Suty C et al (2002) Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 288:75–81CrossRefPubMed
7.
go back to reference Cabell CH, Jollis JG, Peterson GE et al (2002) Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 162:90–94CrossRefPubMed Cabell CH, Jollis JG, Peterson GE et al (2002) Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 162:90–94CrossRefPubMed
8.
go back to reference Murdoch DR, Corey GR, Hoen B et al (2009) Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis–Prospective Cohort Study. Arch Intern Med 169:463–473PubMedCentralCrossRefPubMed Murdoch DR, Corey GR, Hoen B et al (2009) Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis–Prospective Cohort Study. Arch Intern Med 169:463–473PubMedCentralCrossRefPubMed
9.
go back to reference Federspiel JJ, Stearns SC, Peppercorn AF, Chu VH, Fowler VG Jr (2012) Increasing US rates of endocarditis with Staphylococcus aureus: 1999–2008. Arch Intern Med 172:363–365PubMedCentralCrossRefPubMed Federspiel JJ, Stearns SC, Peppercorn AF, Chu VH, Fowler VG Jr (2012) Increasing US rates of endocarditis with Staphylococcus aureus: 1999–2008. Arch Intern Med 172:363–365PubMedCentralCrossRefPubMed
10.
go back to reference Kern WV (2010) Management of Staphylococcus aureus bacteremia and endocarditis: progresses and challenges. Curr Opin Infect Dis 23:346–358CrossRefPubMed Kern WV (2010) Management of Staphylococcus aureus bacteremia and endocarditis: progresses and challenges. Curr Opin Infect Dis 23:346–358CrossRefPubMed
11.
go back to reference Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309–317CrossRefPubMed Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309–317CrossRefPubMed
12.
go back to reference Benito N, Miro JM, de Lazzari E et al (2009) Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med 150:586–594PubMedCentralCrossRefPubMed Benito N, Miro JM, de Lazzari E et al (2009) Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med 150:586–594PubMedCentralCrossRefPubMed
13.
go back to reference Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods MC, Peetermans WE (2007) Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J 28:196–203CrossRefPubMed Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods MC, Peetermans WE (2007) Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J 28:196–203CrossRefPubMed
14.
go back to reference Fowler VG Jr, Miro JM, Hoen B et al (2005) Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293:3012–3021CrossRefPubMed Fowler VG Jr, Miro JM, Hoen B et al (2005) Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293:3012–3021CrossRefPubMed
15.
go back to reference Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36:53–59CrossRefPubMed Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36:53–59CrossRefPubMed
16.
go back to reference Kaasch AJ, Barlow G, Edgeworth JD et al (2014) Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies. J Infect 68:242–251PubMedCentralCrossRefPubMed Kaasch AJ, Barlow G, Edgeworth JD et al (2014) Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies. J Infect 68:242–251PubMedCentralCrossRefPubMed
17.
go back to reference Thuny F, Di Salvo G, Belliard O et al (2005) Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation 112:69–75CrossRefPubMed Thuny F, Di Salvo G, Belliard O et al (2005) Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation 112:69–75CrossRefPubMed
18.
go back to reference Turnidge JD, Kotsanas D, Munckhof W et al (2009) Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med J Aust 191:368–373PubMed Turnidge JD, Kotsanas D, Munckhof W et al (2009) Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med J Aust 191:368–373PubMed
19.
go back to reference Baddour LM, Wilson WR, Bayer AS et al (2015) Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation 132(15):1435–1486CrossRefPubMed Baddour LM, Wilson WR, Bayer AS et al (2015) Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation 132(15):1435–1486CrossRefPubMed
20.
go back to reference Fowler VG Jr, Li J, Corey GR et al (1997) Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 30:1072–1078CrossRefPubMed Fowler VG Jr, Li J, Corey GR et al (1997) Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 30:1072–1078CrossRefPubMed
21.
go back to reference Roder BL, Wandall DA, Frimodt-Moller N, Espersen F, Skinhoj P, Rosdahl VT (1999) Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. Arch Intern Med 159:462–469CrossRefPubMed Roder BL, Wandall DA, Frimodt-Moller N, Espersen F, Skinhoj P, Rosdahl VT (1999) Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. Arch Intern Med 159:462–469CrossRefPubMed
22.
go back to reference Casella F, Rana B, Casazza G et al (2009) The potential impact of contemporary transthoracic echocardiography on the management of patients with native valve endocarditis: a comparison with transesophageal echocardiography. Echocardiography 26:900–906CrossRefPubMed Casella F, Rana B, Casazza G et al (2009) The potential impact of contemporary transthoracic echocardiography on the management of patients with native valve endocarditis: a comparison with transesophageal echocardiography. Echocardiography 26:900–906CrossRefPubMed
23.
go back to reference Bonow RO, Carabello BA, Chatterjee K et al (2008) 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 118:e523–e661CrossRefPubMed Bonow RO, Carabello BA, Chatterjee K et al (2008) 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 118:e523–e661CrossRefPubMed
24.
go back to reference Rasmussen RV, Host U, Arpi M et al (2011) Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography. Eur J Echocardiogr 12:414–420PubMedCentralCrossRefPubMed Rasmussen RV, Host U, Arpi M et al (2011) Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography. Eur J Echocardiogr 12:414–420PubMedCentralCrossRefPubMed
25.
go back to reference Chu VH, Bayer AS (2007) Use of echocardiography in the diagnosis and management of infective endocarditis. Curr Infect Dis Rep 9:283–290CrossRefPubMed Chu VH, Bayer AS (2007) Use of echocardiography in the diagnosis and management of infective endocarditis. Curr Infect Dis Rep 9:283–290CrossRefPubMed
26.
go back to reference Van Hal SJ, Mathur G, Kelly J, Aronis C, Cranney GB, Jones PD (2005) The role of transthoracic echocardiography in excluding left sided infective endocarditis in Staphylococcus aureus bacteraemia. J Infect 51:218–221CrossRefPubMed Van Hal SJ, Mathur G, Kelly J, Aronis C, Cranney GB, Jones PD (2005) The role of transthoracic echocardiography in excluding left sided infective endocarditis in Staphylococcus aureus bacteraemia. J Infect 51:218–221CrossRefPubMed
27.
go back to reference Habib G, Hoen B, Tornos P et al (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 30:2369–2413CrossRefPubMed Habib G, Hoen B, Tornos P et al (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 30:2369–2413CrossRefPubMed
28.
go back to reference Showler A, Burry L, Bai AD et al (2015) Use of transthoracic echocardiography in the management of low-risk staphylococcus aureus bacteremia: results from a retrospective multicenter cohort study. J Am Coll Cardiol Img 8:924–931CrossRef Showler A, Burry L, Bai AD et al (2015) Use of transthoracic echocardiography in the management of low-risk staphylococcus aureus bacteremia: results from a retrospective multicenter cohort study. J Am Coll Cardiol Img 8:924–931CrossRef
29.
go back to reference Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128–140CrossRefPubMed Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128–140CrossRefPubMed
30.
go back to reference Li JS, Sexton DJ, Mick N et al (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633–638CrossRefPubMed Li JS, Sexton DJ, Mick N et al (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633–638CrossRefPubMed
31.
go back to reference Neuner EA, Casabar E, Reichley R, McKinnon PS (2010) Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis 67:228–233CrossRefPubMed Neuner EA, Casabar E, Reichley R, McKinnon PS (2010) Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis 67:228–233CrossRefPubMed
32.
go back to reference Fowler VG Jr, Justice A, Moore C et al (2005) Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis 40:695–703CrossRefPubMed Fowler VG Jr, Justice A, Moore C et al (2005) Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis 40:695–703CrossRefPubMed
33.
go back to reference Hill EE, Vanderschueren S, Verhaegen J et al (2007) Risk factors for infective endocarditis and outcome of patients with Staphylococcus aureus bacteremia. Mayo Clin Proc 82:1165–1169CrossRefPubMed Hill EE, Vanderschueren S, Verhaegen J et al (2007) Risk factors for infective endocarditis and outcome of patients with Staphylococcus aureus bacteremia. Mayo Clin Proc 82:1165–1169CrossRefPubMed
34.
go back to reference Uslan DZ, Sohail MR, St Sauver JL et al (2007) Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med 167:669–675CrossRefPubMed Uslan DZ, Sohail MR, St Sauver JL et al (2007) Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med 167:669–675CrossRefPubMed
35.
go back to reference Robinson DL, Fowler VG, Sexton DJ, Corey RG, Conlon PJ (1997) Bacterial endocarditis in hemodialysis patients. Am J Kidney Dis 30:521–524CrossRefPubMed Robinson DL, Fowler VG, Sexton DJ, Corey RG, Conlon PJ (1997) Bacterial endocarditis in hemodialysis patients. Am J Kidney Dis 30:521–524CrossRefPubMed
36.
go back to reference Pigrau C, Almirante B, Flores X et al (2005) Spontaneous pyogenic vertebral osteomyelitis and endocarditis: incidence, risk factors, and outcome. Am J Med 118:1287CrossRefPubMed Pigrau C, Almirante B, Flores X et al (2005) Spontaneous pyogenic vertebral osteomyelitis and endocarditis: incidence, risk factors, and outcome. Am J Med 118:1287CrossRefPubMed
37.
go back to reference Jensen AG, Espersen F, Skinhoj P, Rosdahl VT, Frimodt-Moller N (1997) Increasing frequency of vertebral osteomyelitis following Staphylococcus aureus bacteraemia in Denmark 1980–1990. J Infect 34:113–118CrossRefPubMed Jensen AG, Espersen F, Skinhoj P, Rosdahl VT, Frimodt-Moller N (1997) Increasing frequency of vertebral osteomyelitis following Staphylococcus aureus bacteraemia in Denmark 1980–1990. J Infect 34:113–118CrossRefPubMed
38.
go back to reference Knudsen JB, Fuursted K, Petersen E et al (2011) Failure of clinical features of low probability endocarditis. The early echo remains essential. Scand Cardiovasc J 45:133–138CrossRefPubMed Knudsen JB, Fuursted K, Petersen E et al (2011) Failure of clinical features of low probability endocarditis. The early echo remains essential. Scand Cardiovasc J 45:133–138CrossRefPubMed
39.
go back to reference Crowley AL, Peterson GE, Benjamin DK Jr et al (2008) Venous thrombosis in patients with short- and long-term central venous catheter-associated Staphylococcus aureus bacteremia. Crit Care Med 36:385–390CrossRefPubMed Crowley AL, Peterson GE, Benjamin DK Jr et al (2008) Venous thrombosis in patients with short- and long-term central venous catheter-associated Staphylococcus aureus bacteremia. Crit Care Med 36:385–390CrossRefPubMed
40.
go back to reference Miro JM, Anguera I, Cabell CH et al (2005) Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 41:507–514CrossRefPubMed Miro JM, Anguera I, Cabell CH et al (2005) Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 41:507–514CrossRefPubMed
41.
go back to reference Chang FY, MacDonald BB, Peacock JE Jr, Musher DM, Triplett P, Mylotte JM et al (2003) A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine 82:322–332CrossRefPubMed Chang FY, MacDonald BB, Peacock JE Jr, Musher DM, Triplett P, Mylotte JM et al (2003) A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine 82:322–332CrossRefPubMed
42.
go back to reference Das I, O’Connell N, Lambert P (2007) Epidemiology, clinical and laboratory characteristics of Staphylococcus aureus bacteraemia in a university hospital in UK. J Hosp Infect 65:117–123CrossRefPubMed Das I, O’Connell N, Lambert P (2007) Epidemiology, clinical and laboratory characteristics of Staphylococcus aureus bacteraemia in a university hospital in UK. J Hosp Infect 65:117–123CrossRefPubMed
43.
go back to reference Fowler VG Jr, Olsen MK, Corey GR et al (2003) Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 163:2066–2072CrossRefPubMed Fowler VG Jr, Olsen MK, Corey GR et al (2003) Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 163:2066–2072CrossRefPubMed
44.
go back to reference Abraham J, Mansour C, Veledar E, Khan B, Lerakis S (2004) Staphylococcus aureus bacteremia and endocarditis: the Grady Memorial Hospital experience with methicillin-sensitive S aureus and methicillin-resistant S aureus bacteremia. Am Heart J 147:536–539CrossRefPubMed Abraham J, Mansour C, Veledar E, Khan B, Lerakis S (2004) Staphylococcus aureus bacteremia and endocarditis: the Grady Memorial Hospital experience with methicillin-sensitive S aureus and methicillin-resistant S aureus bacteremia. Am Heart J 147:536–539CrossRefPubMed
45.
go back to reference Vos FJ, Bleeker-Rovers CP, Sturm PD et al (2011) Endocarditis: effects of routine echocardiography during Gram-positive bacteraemia. Neth J Med 69:335–340PubMed Vos FJ, Bleeker-Rovers CP, Sturm PD et al (2011) Endocarditis: effects of routine echocardiography during Gram-positive bacteraemia. Neth J Med 69:335–340PubMed
46.
go back to reference Chen R, Yan ZQ, Feng D, Luo YP, Wang LL, Shen DX (2012) Nosocomial bloodstream infection in patients caused by Staphylococcus aureus: drug susceptibility, outcome, and risk factors for hospital mortality. Chin Med J 125:226–229PubMed Chen R, Yan ZQ, Feng D, Luo YP, Wang LL, Shen DX (2012) Nosocomial bloodstream infection in patients caused by Staphylococcus aureus: drug susceptibility, outcome, and risk factors for hospital mortality. Chin Med J 125:226–229PubMed
47.
go back to reference Stevens V, Lodise TP, Tsuji B et al (2012) The utility of acute physiology and chronic health evaluation II scores for prediction of mortality among intensive care unit (ICU) and non-ICU patients with methicillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 33:558–564CrossRefPubMed Stevens V, Lodise TP, Tsuji B et al (2012) The utility of acute physiology and chronic health evaluation II scores for prediction of mortality among intensive care unit (ICU) and non-ICU patients with methicillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 33:558–564CrossRefPubMed
48.
go back to reference Naber CK, Baddour LM, Giamarellos-Bourboulis EJ et al (2009) Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus. Clin Infect Dis 48(Suppl 4):S260–S270CrossRefPubMed Naber CK, Baddour LM, Giamarellos-Bourboulis EJ et al (2009) Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus. Clin Infect Dis 48(Suppl 4):S260–S270CrossRefPubMed
49.
go back to reference Honda H, Krauss MJ, Jones JC, Olsen MA, Warren DK (2010) The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med 123:631–637PubMedCentralCrossRefPubMed Honda H, Krauss MJ, Jones JC, Olsen MA, Warren DK (2010) The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med 123:631–637PubMedCentralCrossRefPubMed
50.
go back to reference Nagao M, Iinuma Y, Saito T et al (2009) Close cooperation between infectious disease physicians and attending physicians results in better outcomes for patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect 16:1783CrossRef Nagao M, Iinuma Y, Saito T et al (2009) Close cooperation between infectious disease physicians and attending physicians results in better outcomes for patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect 16:1783CrossRef
51.
go back to reference Uslan DZ, Dowsley TF, Sohail MR et al (2010) Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia. Pacing Clin Electrophysiol 33:407–413CrossRefPubMed Uslan DZ, Dowsley TF, Sohail MR et al (2010) Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia. Pacing Clin Electrophysiol 33:407–413CrossRefPubMed
Metadata
Title
Simplified risk stratification criteria for identification of patients with MRSA bacteremia at low risk of infective endocarditis: implications for avoiding routine transesophageal echocardiography in MRSA bacteremia
Authors
P. Buitron de la Vega
P. Tandon
W. Qureshi
Y. Nasr
R. Jayaprakash
S. Arshad
D. Moreno
G. Jacobsen
K. Ananthasubramaniam
M. Ramesh
M. Zervos
Publication date
01-02-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 2/2016
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-015-2539-y

Other articles of this Issue 2/2016

European Journal of Clinical Microbiology & Infectious Diseases 2/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.